Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Fermenta Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:506414NSE Symbol: Not ListedP/E(TTM):57.34
ISIN Demat:INE225B01021Div & Yield %:0.69EPS(TTM):3.08
Book Value(Rs):105.2575279Market Cap ( Cr.):519.75Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 328.92387.96372.82300.51404.6712.51
Excise Duty0.000.000.001.241.220.00
Net Sales328.92387.96372.82299.27403.4512.51
Other Income 7.567.536.6212.3112.340.38
Stock Adjustments -17.29-7.6515.8820.7912.820.00
Total Income319.19387.84395.32332.37428.6112.89
EXPENDITURE :      
Raw Materials 109.21136.55139.52103.46105.080.00
Power & Fuel Cost18.2420.3514.2312.7413.882.47
Employee Cost 53.7259.3657.5050.0353.185.77
Other Manufacturing Expenses 44.1243.6536.0627.8531.073.13
Selling and Administration Expenses 36.8038.1637.2547.2853.132.98
Miscellaneous Expenses 69.785.429.418.2518.017.55
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure331.87303.50293.96249.61274.3521.89
Operating Profit-12.6884.35101.3682.75154.27-9.01
Interest 21.4918.1119.1020.2721.3010.63
Gross Profit-34.1766.2482.2662.48132.97-19.64
Depreciation24.5123.6719.0314.9411.853.83
Profit Before Tax-58.6842.5763.2347.54121.12-23.47
Tax-1.167.4111.263.3731.920.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.004.920.00-19.49-21.150.69
Reported Net Profit-57.5330.2451.9763.67110.35-24.15
Extraordinary Items -59.90-0.02-0.131.90-4.78-0.06
Adjusted Net Profit2.3730.2652.1061.77115.13-24.09
Adjst. below Net Profit 0.11-0.24-0.04-6.2298.95-0.05
P & L Balance brought forward350.72327.93275.99218.549.2434.14
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 3.617.210.000.000.000.69
P & L Balance carried down289.69350.72327.93275.99218.549.24
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %25.0025.0050.00100.0025.0025.00
Earnings Per Share-Unit Curr-19.9410.4818.0122.07120.300.00
Earnings Per Share(Adj)-Unit Curr-19.9410.4818.0122.0740.100.00
Book Value-Unit Curr115.77137.26128.42108.36271.74282.22